We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
EPCORITAMAB MONOTHERAPY AND COMBINATIONS IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR RICHTER'S SYNDROME: NEW ESCALATION AND EXPANSION COHORTS IN EPCORE CLL‐1.
- Authors
Eichhorst, B.; Eradat, H.; Niemann, C. U.; Oki, T.; Kuznetsova, A.; Rios, M.; Valentin, R.; Kater, A. P.
- Abstract
EPCORITAMAB MONOTHERAPY AND COMBINATIONS IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR RICHTER'S SYNDROME: NEW ESCALATION AND EXPANSION COHORTS IN EPCORE CLL-1 B Introduction: b Targeted therapies have dramatically changed the treatment landscape of chronic lymphocytic leukemia (CLL). Epcoritamab + venetoclax will be evaluated in patients with I R i / I R i CLL requiring treatment per iwCLL.
- Subjects
CHRONIC lymphocytic leukemia; RICHTER syndrome; BRUTON tyrosine kinase
- Publication
Hematological Oncology, 2023, Vol 41, p828
- ISSN
0278-0232
- Publication type
Article
- DOI
10.1002/hon.3166_OT10